MoonLake Immunotherapeutics
MLTX
$17.80
-$0.20-1.11%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 357.92M | 393.97M | 380.48M | 425.08M | 480.13M |
| Total Receivables | 5.76M | 4.87M | 4.02M | 3.41M | 2.99M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 32.96M | 22.86M | 26.71M | 26.99M | 23.15M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 396.64M | 421.69M | 411.22M | 455.48M | 506.26M |
|
|
|||||
| Total Current Assets | 396.64M | 421.69M | 411.22M | 455.48M | 506.26M |
| Net Property, Plant & Equipment | 2.39M | 2.14M | 2.53M | 2.92M | 3.30M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.34M | 596.00K | 587.00K | 1.70M | 1.70M |
| Total Assets | 400.37M | 424.43M | 414.34M | 460.10M | 511.26M |
|
|
|||||
| Total Accounts Payable | 23.38M | 365.00K | 653.00K | 602.00K | 14.00K |
| Total Accrued Expenses | 20.42M | 42.79M | 45.20M | 24.37M | 20.30M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 920.00K | 1.23M | 1.50M | 1.55M | 1.43M |
| Total Finance Division Other Current Liabilities | 1.40M | 1.09M | 1.01M | 836.00K | 2.23M |
| Total Other Current Liabilities | 1.40M | 1.09M | 1.01M | 836.00K | 2.23M |
| Total Current Liabilities | 46.11M | 45.48M | 48.37M | 27.36M | 23.98M |
|
|
|||||
| Total Current Liabilities | 46.11M | 45.48M | 48.37M | 27.36M | 23.98M |
| Long-Term Debt | 99.02M | 74.10M | 73.74M | 73.38M | 73.02M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 865.00K | 374.00K | 486.00K | 836.00K | 1.14M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 353.00K | -- | 549.00K | 574.00K | 536.00K |
| Total Liabilities | 146.35M | 119.95M | 123.14M | 102.15M | 98.68M |
|
|
|||||
| Common Stock & APIC | 786.32M | 766.79M | 689.11M | 683.97M | 680.67M |
| Retained Earnings | -532.62M | -462.91M | -400.49M | -330.76M | -275.54M |
| Treasury Stock & Other | 322.00K | 604.00K | 278.00K | 520.00K | 2.39M |
| Total Common Equity | 254.02M | 304.48M | 288.91M | 353.73M | 407.52M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 254.02M | 304.48M | 288.91M | 353.73M | 407.52M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | 2.29M | 4.21M | 5.06M |
| Total Equity | 254.02M | 304.48M | 291.19M | 357.94M | 412.58M |
|
|
|||||